Showing results (1081-1090 of 1,136) with videos related to
Sort By:
Pageof 114
Bipolar Disorders|July 18, 2023
Patterns of pharmacotherapy for bipolar disorder: A GBC surveyBalwinder Singh, Anastasia K Yocum, Rebecca Strawbridge, et al.Bipolar Disorders|May 23, 2012
Impact of sunlight on the age of onset of bipolar disorderMichael Bauer, Tasha Glenn, Martin Alda, et al.The British Journal of Psychiatry : the Journal of Mental Science|December 18, 2023
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trialColleen Loo, Nick Glozier, David Barton, et al.JAMA Psychiatry|April 1, 2026
Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical TrialRebecca McKetin, Steven Shoptaw, Lucy Saunders, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 6, 2022
Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designsMiriam von Mücke Similon, Cecilia Paasche, Fas Krol, et al.Journal of Clinical Psychopharmacology|March 13, 2026
The Candesartan Adjunctive Depression Trials-CADET: Study Protocols for Double-Blind, Randomized, Placebo-Controlled Trials for Bipolar Depression and Major Depressive DisorderMelanie M Ashton, Chun Hui J Park, Brisa S Fernandes, et al.Molecular Psychiatry|December 12, 2022
In vivo white matter microstructure in adolescents with early-onset psychosis: a multi-site mega-analysisClaudia Barth, Sinead Kelly, Stener Nerland, et al.Molecular Psychiatry|January 10, 2024
Mapping gray and white matter volume abnormalities in early-onset psychosis: an ENIGMA multicenter voxel-based morphometry studyShuqing Si, Anbreen Bi, Zhaoying Yu, et al.Human Brain Mapping|October 5, 2020
Intracranial and subcortical volumes in adolescents with early-onset psychosis: A multisite mega-analysis from the ENIGMA consortiumTiril P Gurholt, Vera Lonning, Stener Nerland, et al.The British Journal of Psychiatry : the Journal of Mental Science|March 25, 2026
The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensusJoseph F Goldberg, Holly A Swartz, Roger S McIntyre, et al.Pageof 114